Biopool Shows 78% Drop in Quarterly Profit

Biopool International Inc., a Ventura maker of test kits for diagnosing blood disorders, said its third-quarter profit plummeted 78% on an 18% decline in revenue.

For the quarter that ended Sept. 30, the company earned $32,629, compared with $145,169 a year earlier. Quarterly sales were $1.03 million, down from $1.26 million a year earlier. Biopool said third-quarter results were hurt by uncertainty in the Italian medical diagnostics market and an unfavorable exchange rate in Sweden, where Biopool operates a subsidiary.

For the nine months that ended Sept. 30, Biopool’s profit fell 63% to $161,736, from $438,378 a year earlier. Revenue totaled $3.2 million, down 18% from $3.91 million.